The Brainsway Deep TMS System is cleared by the U.S. Food and Drug Administration (FDA) for the treatment of depressive episodes in adult patients suffering from depression, and who have failed to achieve adequate improvement from anti-depressant and augmentive medication. It is also now cleared for the treatment of obsessive-compulsive disorder (OCD).
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive treatment for depression and OCD. It works by applying brief magnetic pulses to the brain. These pulses create an electric field which has been shown to produce excitations and/or the inhibition of neurons deep inside the brain.
Our therapy is referred to as “Deep TMS” because, unlike traditional TMS therapy, Deep dTMS reaches into the deeper (limbic) areas of the brain that impact mood regulation and motivation.